Voltaren (diclofenac) is licensed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain, and decades-genericised diclofenac sodium and diclofenac potassium tablets now sit alongside the originator brand on every formulary M Care serves.
M Care Exports is a merchant exporter: we source Voltaren/Voltarol and long-genericised diclofenac sodium and diclofenac potassium lines through licensed Indian manufacturing and distribution channels and dispatch on quote, not from our own production.
Diclofenac exporter and bulk supplier from India.
For hospital, wholesaler and MoH tender orders, M Care quotes diclofenac against buyer specification: gastro-resistant or immediate-release tablet, suppository, intramuscular injection or topical gel, brand or generic, and destination-market regulatory documentation. Because diclofenac carries an FDA and EU class-wide NSAID cardiovascular and gastrointestinal warning and a third-trimester pregnancy contraindication, we confirm the buyer's intended formulary counselling material and pack-insert language before dispatch, then align CTD/eCTD or country-specific dossier paperwork to the destination regulator's requirements.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Non-steroidal anti-inflammatory drug (NSAID); phenylacetic acid derivative, sourced and documented for export.
Diclofenac is a phenylacetic-acid derivative NSAID. It inhibits both cyclo-oxygenase-1 and cyclo-oxygenase-2, reducing prostaglandin synthesis to relieve pain and inflammation, with a COX-2 preference that is more pronounced in its topical gel form than in the oral tablet. It is dosed orally, rectally or by intramuscular injection, or applied topically; no reconstitution is needed for any presentation. The FDA-labelled indication for diclofenac sodium delayed-release tablets covers relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; the UK-licensed diclofenac potassium immediate-release tablet additionally covers acute musculoskeletal disorders, low back pain, migraine attack, acute gout and post-operative pain. Destination-country labelling should be checked against this before a tender quote is finalised. Diclofenac is supplied as 25 mg, 50 mg and 75 mg gastro-resistant tablets, a 50 mg immediate-release diclofenac potassium tablet, a 75 mg/3 mL intramuscular injection and a 100 mg suppository, alongside topical gel for musculoskeletal strains.
Active ingredient
Diclofenac sodium (tablet, suppository, injection); diclofenac potassium (immediate-release tablet). Non-steroidal anti-inflammatory drug (NSAID); phenylacetic acid derivative.
Forms and strengths
25 mg gastro-resistant tablet; 50 mg gastro-resistant tablet; 75 mg gastro-resistant tablet; 50 mg immediate-release tablet (diclofenac potassium); 75 mg/3ml solution for injection; 100 mg suppository.
Indications
Diclofenac is a phenylacetic-acid NSAID indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain. Supplied from Indian manufacturing channels as both the Voltaren/Voltarol brand and long-genericised diclofenac sodium and diclofenac potassium lines, to regulated and semi-regulated export markets.
Administration
Oral, Rectal, Intramuscular, Topical. Gastro-resistant tablet and immediate-release tablet, with suppository, intramuscular injection and topical gel presentations also supplied.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers for diclofenac are hospital orthopaedic, rheumatology and general-surgery pharmacies stocking a standard post-operative and chronic-pain analgesic line, national and regional MoH tender desks running musculoskeletal and pain-management formulary lists, licensed pharmaceutical wholesalers and importers, and NGO or primary-care procurement programmes supplying a baseline NSAID across our GCC and African markets.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on diclofenac.
Diclofenac's class-wide NSAID warning is the dispensing point that matters most: the FDA label carries a boxed warning for cardiovascular thrombotic events and for gastrointestinal bleeding, ulceration and perforation, and the EU SmPC carries an equivalent caution, so the lowest effective dose for the shortest duration is the working rule at every strength. Diclofenac sodium delayed-release tablets are contraindicated around coronary artery bypass graft surgery, and diclofenac potassium immediate-release tablets are contraindicated in the third trimester of pregnancy. Total daily dose should not exceed 150 mg across oral, rectal and injectable routes combined if more than one presentation is co-prescribed, since patients switching from suppository to tablet mid-course are an easy double-dosing error to miss on medicines reconciliation. The intramuscular injection is for deep gluteal administration only, never intravenous push, and is typically limited to one to two days before stepping down to oral or rectal dosing. Diclofenac raises lithium, digoxin and methotrexate plasma levels and reduces the antihypertensive effect of ACE inhibitors and diuretics, so a concurrent-medicines check belongs on every dispensing label.
The documentation pack a regulator actually asks for.
As an oral, rectal and topical NSAID with no biologic component, diclofenac ships on standard ambient-temperature logistics rather than the validated cold-chain lanes M Care runs for insulins and biologics; even the intramuscular injection is a room-temperature solution. What buyers need instead is the standard batch-level certificate of analysis, CDSCO export documentation and, where the destination regulator requires local registration, CTD or eCTD-format dossier support. Diclofenac is not carried on the current WHO Model List of Essential Medicines, having been excluded over its cardiovascular and gastrointestinal safety profile relative to other NSAIDs, but it remains on many national essential-medicines and hospital formulary lists across the GCC and Africa as a staple post-operative and musculoskeletal analgesic, which keeps tender volume high independent of WHO-EML status. Diclofenac is not a scheduled controlled substance in the markets M Care serves. UK pharmacies did face a 2025 DHSC medicine supply notification (MSN/2025/042, Tier 2) for a preservative-free diclofenac ophthalmic drop, a different presentation from the oral, rectal and injectable lines M Care exports, but it is a live reminder of why formulary desks keep a secondary source on file even for a genericised molecule.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside diclofenac.
Deflazacort
Another musculoskeletal & pain line ordered on the same formularies.
Denosumab
Another musculoskeletal & pain line ordered on the same formularies.
Etoricoxib
Another musculoskeletal & pain line ordered on the same formularies.
All musculoskeletal & pain
The full category listing for procurement desks.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for diclofenac.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Diclofenac supply, the specific questions.
Does a generic version of Voltaren/Voltarol exist?
Yes. Diclofenac sodium and diclofenac potassium have been off-patent for decades, with numerous licensed diclofenac sodium generic entries in the UK and multiple FDA-approved generic manufacturers alongside the Voltaren/Voltarol brand. M Care quotes brand or generic against your tender specification and destination-market registration status.
Which international brand names does diclofenac go by?
Voltaren is the name used across most export markets M Care serves; the same originator product is sold as Voltarol in the UK and Ireland, and diclofenac potassium is separately marketed by Novartis as Cataflam in several countries. Destination-market labelling and pack artwork should be confirmed against the specific brand name your tender or formulary specifies.
What strengths and forms of diclofenac can M Care supply?
25 mg, 50 mg and 75 mg gastro-resistant tablets, a 50 mg immediate-release diclofenac potassium tablet, a 75 mg/3 mL intramuscular injection, a 100 mg suppository and topical gel. Tell us your dosing protocol, indication mix and preferred route and we quote the pack format accordingly.
Is diclofenac on the WHO Essential Medicines List?
No. Diclofenac was excluded from the current WHO Model List of Essential Medicines over its cardiovascular and gastrointestinal safety profile relative to other NSAIDs. It nonetheless remains a common presence on national essential-medicines lists and hospital formularies across the GCC and Africa as a standard post-operative and musculoskeletal analgesic.
Does diclofenac need cold-chain shipping?
No. Every diclofenac presentation M Care supplies, tablet, suppository, intramuscular injection and topical gel, is stored at controlled room temperature and moves on standard ambient logistics, not the validated cold-chain lanes we use for biologics and vaccines.
What documentation does M Care provide with a diclofenac shipment?
A batch-specific certificate of analysis, CDSCO export documentation from the Indian side, and CTD/eCTD-aligned dossier support where the destination regulator requires local registration before import, alongside confirmation of exactly which brand or generic product a shipment contains.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-09-13.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.